Partners HealthCare System has raised has raised $171 million for a second innovation fund targeting seed stage investments in life science startups, according to a news release. The Brigham and Women’s Hospital and Massachusetts General Hospital each committed $50 million for the fund.
Several pharma companies have backed Partners Innovation Fund II such as Astellas Pharma, Eli Lilly, Shang Pharma Corp., and Simcere Pharmaceutical Group. The fund will invest in 15-20 companies, said Roger Kitterman, Vice President of Partners Innovation, in an email.
